This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics.
Annals of the rheumatic diseases, 71(1), 143-9
Citation
Vessillier, Sandrine; Adams, Gill; Montero-Melendez, Trinidad; Jones, Rita; Seed, Michael; Perretti, Mauro; Chernajovsky, Yuti. (2012). Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics.. Annals of the rheumatic diseases, 71(1), 143-9. https://doi.org/10.1136/annrheumdis-2011-200100